84.9
Candel Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
71.9
FY23:
36.8
FY24:
104
FY25:
121
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.26
FY22:
5.75
FY23:
4.40
FY24:
3.06
FY25:
3.81
Total assets
Change from FY21 to FY25
millions USD
FY21:
89.2
FY22:
77.7
FY23:
41.2
FY24:
107
FY25:
125
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.36
FY22:
5.62
FY23:
14.2
FY24:
37.5
FY25:
9.00
(negative)
Change from FY21 to FY25
millions USD
FY21:
19.7
FY22:
24.4
FY23:
14.3
FY24:
3.01
FY25:
64.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
64.1
FY22:
47.7
FY23:
12.7
FY24:
66.3
FY25:
51.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
89.2
FY22:
77.7
FY23:
41.2
FY24:
107
FY25:
125
All amounts in millions USD